P7C3 is a novel and potent pro-neurogenic, neuro-protective small molecule, orally available and brain penetrant, discovered from an in vivo screening in mice. It can protect newborn neurons in the dentate gyrus and stimulates the growth of new neurons. It can also enhance learning and memory in aged rats. P7C3 can preserve axonal integrity after injury, before neuronal cell death occurs, in a rodent model of blast-mediated traumatic brain injury (TBI). MOA study showed P7C3 could bind nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme involved in the conversion of nicotinamide into nicotinamide adenine dinucleotide (NAD). Administration of active P7C3 chemicals to cells treated with doxorubicin, which induces NAD depletion, led to a rebound in intracellular levels of NAD and concomitant protection from doxorubicin-mediated toxicity.
CAS Number: 301353-96-8
Molecular Weight: 474.19
Chemical Name: 1-(3,6-dibromo-9H-carbazol-9-yl)-3-(phenylamino)propan-2-ol
Appearance: Solid Power.
Purity: ≥98% (or refer to the Certificate of Analysis)
Solubility: DMSO up to 100 mM
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥360 days if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined.
HS Tariff Code: 382200
How to use
P7C3 was orally administrated to mice at 5-10 mg/kg once per day. It displays favorable distribution into the brain (AUC brain/AUC plasma ratio of 3.7 for oral delivery).
- Pieper AA, et al. Discovery of a proneurogenic, neuroprotective chemical. (2010) Cell 142(1), 39-51.
- Saxe JP. Screening: Your brain on drugs. (2010) Nat Chem Biol. 6(9):639-40
- MacMillan KS, et al. Development of Proneurogenic, Neuroprotective Small Molecules. (2011) Journal of the American Chemical Society, 133(5), 1428-1437.
- De Jesús-Cortés H, et al. Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease. (2012) Proc Natl Acad Sci USA. 109(42):17010-5.
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.